<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=10087185" created="12/05/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>10087185</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Decreased <term id="T2" lex="proteasome" sem="Protein_complex">proteasome</term>-mediated <term id="A43" sem="Other">degradation</term> in <term id="T3" lex="T_cell" sem="Cell_natural">T cells</term> from the <term id="T4" lex="elderly" sem="Multicellular_organism_natural">elderly</term>: A role in <term id="T5" lex="immune_senescence" sem="Other">immune senescence</term>.</sentence>
<event KT="Other" id="E1">
<type class="Positive_regulation"/>
<theme idref="A43"/>
<cause idref="T2"/>
<clue>Decreased proteasome-<clueType>mediated</clueType> degradation in T cells from the elderly: A role in immune senescence.</clue>
</event>
<event KT="Investigation" id="E2">
<type class="Negative_regulation"/>
<theme idref="E1"/>
<clue><clueType>Decreased</clueType> proteasome-mediated degradation <clueLoc>in T cells from the elderly</clueLoc>: A role in immune senescence.</clue>
</event>
<event KT="Investigation" id="E3">
<type class="Regulation"/>
<theme idref="T5"/>
<cause idref="E2"/>
<clue>Decreased proteasome-mediated degradation in T cells from the elderly: A <clueType>role</clueType> <linkTheme>in</linkTheme> immune senescence.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Induction of <term id="T6" lex="NFkappaB" sem="Protein_molecule">NFkappaB</term> is a highly regulated process requiring <term id="T7" lex="phosphorylation" sem="Other">phosphorylation</term>, <term id="T8" lex="ubiquitination" sem="Other">ubiquitination</term>, and <term id="T10" lex="proteasome" sem="Protein_complex">proteasome</term>-mediated <term id="T1" sem="Other">degradation</term> of the <term id="T11" lex="cytosolic_inhibitor" sem="Protein_family_or_group">cytosolic inhibitor</term> <term id="T12" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term>.</sentence>
<event KT="Other" id="E4">
<type class="Protein_catabolism"/>
<theme idref="T12"/>
<clue>Induction of NFkappaB is a highly regulated process requiring phosphorylation, ubiquitination, and proteasome-mediated <clueType>degradation</clueType> <linkTheme>of</linkTheme> the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Other" id="E5">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T7"/>
<clue>Induction of NFkappaB is a highly regulated process requiring phosphorylation, ubiquitination, and proteasome-<clueType>mediated</clueType> degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Other" id="E6">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T8"/>
<clue>Induction of NFkappaB is a highly regulated process requiring phosphorylation, ubiquitination, and proteasome-<clueType>mediated</clueType> degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Other" id="E7">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T10"/>
<clue>Induction of NFkappaB is a highly regulated process requiring phosphorylation, ubiquitination, and proteasome-<clueType>mediated</clueType> degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Other" id="E8">
<type class="Positive_regulation"/>
<theme idref="T6"/>
<clue><clueType>Induction</clueType> <linkTheme>of</linkTheme> NFkappaB is a highly regulated process requiring phosphorylation, ubiquitination, and proteasome-mediated degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E5"/>
<clue>Induction of NFkappaB is a highly regulated process <clueType>requiring</clueType> phosphorylation, ubiquitination, and proteasome-mediated degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E6"/>
<clue>Induction of NFkappaB is a highly regulated process <clueType>requiring</clueType> phosphorylation, ubiquitination, and proteasome-mediated degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<event KT="Fact" id="E11">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="E7"/>
<clue>Induction of NFkappaB is a highly regulated process <clueType>requiring</clueType> phosphorylation, ubiquitination, and proteasome-mediated degradation of the cytosolic inhibitor IkappaBalpha.</clue>
</event>
<sentence id="S3">Analyses of the regulation of <term id="T13" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> in <term id="T14" lex="TNF-alpha-treated_T_lymphocyte" sem="Cell_natural"><term id="T15" lex="TNF-alpha" sem="Protein_molecule">TNF-alpha</term>-treated T lymphocytes</term> from <cons id="T16" lex="(AND young_donor elderly_donor)" sem="(AND Multicellular_organism_natural Multicellular_organism_natural)"><frag id="F1">young</frag> and <frag id="F2">elderly</frag> <frag id="F3">donors</frag></cons> revealed severely compromised degradation of <term id="T17" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> in <term id="T18" lex="T_cell" sem="Cell_natural">T cells</term> from the <term id="T19" lex="elderly" sem="Multicellular_organism_natural">elderly</term>.</sentence>
<event KT="Investigation" id="E12" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T13"/>
<clue><clueKT>Analyses</clueKT> of the <clueType>regulation</clueType> <linkTheme>of</linkTheme> IkappaBalpha <clueLoc>in TNF-alpha-treated T lymphocytes from young</clueLoc> and elderly <clueLoc>donors</clueLoc> revealed severely compromised degradation of IkappaBalpha in T cells from the elderly.</clue>
</event>
<event KT="Investigation" id="E112" uncertainty="doubtful">
<type class="Regulation"/>
<theme idref="T13"/>
<clue><clueKT>Analyses</clueKT> of the <clueType>regulation</clueType> <linkTheme>of</linkTheme> IkappaBalpha <clueLoc>in TNF-alpha-treated T lymphocytes from</clueLoc> young and <clueLoc>elderly donors</clueLoc> revealed severely compromised degradation of IkappaBalpha in T cells from the elderly.</clue>
</event>
<event KT="Other" id="E13">
<type class="Protein_catabolism"/>
<theme idref="T17"/>
<clue>Analyses of the regulation of IkappaBalpha in TNF-alpha-treated T lymphocytes from young and elderly donors revealed severely compromised <clueType>degradation</clueType> <linkTheme>of</linkTheme> IkappaBalpha in T cells from the elderly.</clue>
</event>
<event KT="Analysis" Manner="High" id="E14">
<type class="Negative_regulation"/>
<theme idref="E15"/>
<clue>Analyses of the regulation of IkappaBalpha in TNF-alpha-treated T lymphocytes from young and elderly donors <clueKT>revealed</clueKT> <clueManner>severely</clueManner> <clueType>compromised</clueType> degradation of IkappaBalpha <clueLoc>in T cells from the elderly</clueLoc>.</clue>
</event>
<sentence id="S4">Examination of <term id="A1" sem="Other">activation</term>-induced <term id="T9" sem="Other">phosphorylation</term> and ubiquitination of <term id="T21" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> did not demonstrate any significant <term id="T22" lex="age-related_alteration" sem="Other"><term id="A2" sem="Other">age</term>-related alterations</term>.</sentence>
<event KT="Other" id="E15">
<type class="Protein_ubiquitination"/>
<theme idref="T21"/>
<clue>Examination of activation-induced phosphorylation and <clueType>ubiquitination</clueType> <linkTheme>of</linkTheme> IkappaBalpha did not demonstrate any significant age-related alterations.</clue>
</event>
<event KT="Other" id="E16">
<type class="Protein_amino_acid_phosphorylation"/>
<theme idref="T21"/>
<clue>Examination of activation-induced <clueType>phosphorylation</clueType> and ubiquitination <linkTheme>of</linkTheme> IkappaBalpha did not demonstrate any significant age-related alterations.</clue>
</event>
<event KT="Investigation" id="E17">
<type class="Positive_regulation"/>
<theme idref="E15"/>
<cause idref="A1"/>
<clue><clueKT>Examination</clueKT> of activation-<clueType>induced</clueType> phosphorylation and ubiquitination of IkappaBalpha did not demonstrate any significant age-related alterations.</clue>
</event>
<event KT="Investigation" id="E18">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="A1"/>
<clue><clueKT>Examination</clueKT> of activation-<clueType>induced</clueType> phosphorylation and ubiquitination of IkappaBalpha did not demonstrate any significant age-related alterations.</clue>
</event>
<event KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E19">
<type class="Regulation"/>
<theme idref="E17"/>
<cause idref="A2"/>
<clue>Examination of activation-induced phosphorylation and ubiquitination of IkappaBalpha did <cluePolarity>not</cluePolarity> <clueKT>demonstrate</clueKT> any <clueManner>significant</clueManner> age-<linkCause>related</linkCause> <clueType>alterations</clueType>.</clue>
</event>
<event KT="Analysis" Manner="High" Polarity="Negative" assertion="non-exist" id="E20">
<type class="Regulation"/>
<theme idref="E18"/>
<cause idref="A2"/>
<clue>Examination of activation-induced phosphorylation and ubiquitination of IkappaBalpha did <cluePolarity>not</cluePolarity> <clueKT>demonstrate</clueKT> any <clueManner>significant</clueManner> age-<linkCause>related</linkCause> <clueType>alterations</clueType>.</clue>
</event>
<sentence id="S5">However, examination of <term id="T23" lex="proteasome_activity" sem="Other"><term id="T24" lex="proteasome" sem="Protein_complex">proteasome</term> activity</term> in these <term id="T25" lex="T_cell" sem="Cell_natural">T cells</term> using <term id="T26" lex="fluorogenic_peptide_assay" sem="Other">fluorogenic peptide assays</term> revealed a significant <term id="A3" sem="Other">age</term>-related decline in <term id="T28" lex="chymotryptic_activity" sem="Other"><term id="T20" sem="Protein_molecule">chymotryptic</term> activity</term>.</sentence>
<event KT="Other" Manner="High" id="E21">
<type class="Negative_regulation"/>
<theme idref="T28"/>
<clue>However, examination of proteasome activity in these T cells using fluorogenic peptide assays revealed a <clueManner>significant</clueManner> age-related <clueType>decline</clueType> <linkTheme>in</linkTheme> chymotryptic activity.</clue>
</event>
<event KT="Analysis" id="E22">
<type class="Positive_regulation"/>
<theme idref="E21"/>
<cause idref="A3"/>
<clue>However, examination of proteasome activity <clueLoc>in these T cells</clueLoc> <clueExperiment>using fluorogenic peptide assays</clueExperiment> <clueKT>revealed</clueKT> a significant age-<clueType>related</clueType> decline in chymotryptic activity.</clue>
</event>
<sentence id="S6">These results suggest that a decline in <term id="T29" lex="proteasome_activity" sem="Other"><term id="T30" lex="proteasome" sem="Protein_complex">proteasome</term> activity</term> results in a failure to fully degrade <term id="T31" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> in the <term id="T32" lex="elderly" sem="Multicellular_organism_natural">elderly</term>.</sentence>
<event KT="Other" id="E23">
<type class="Negative_regulation"/>
<theme idref="T30"/>
<clue>These results suggest that a <clueType>decline</clueType> <linkTheme>in</linkTheme> proteasome activity results in a failure to fully degrade IkappaBalpha in the elderly.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E24">
<type class="Protein_catabolism"/>
<theme idref="T31"/>
<clue>These results suggest that a decline in proteasome activity results in a <cluePolarity>failure</cluePolarity> to fully <clueType>degrade</clueType> IkappaBalpha <clueLoc>in the elderly</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E25" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E23"/>
<clue>These results <clueKT><clueCL>suggest</clueCL></clueKT> that a decline in proteasome activity <clueType>results</clueType> <linkTheme>in</linkTheme> a failure to fully degrade IkappaBalpha in the elderly.</clue>
</event>
<sentence id="S7">This failure to degrade <term id="T33" lex="IkappaBalpha" sem="Protein_molecule">IkappaBalpha</term> may underlie both the observed decrease in <term id="T34" lex="NFkappaB_induction" sem="Other"><term id="T35" lex="NFkappaB" sem="Protein_molecule">NFkappaB</term> induction</term> and the <term id="T36" lex="IL-2_receptor_expression" sem="Other"><term id="T27" sem="Protein_molecule">IL-2 receptor</term> expression</term> in <term id="T37" sem="Protein_molecule">TNF</term>-treated <term id="T39" lex="T_cell" sem="Cell_natural">T cells</term> during aging.</sentence>
<event KT="Method" id="E37">
<type class="Artificial_process"/>
<theme idref="T37"/>
<theme idref="T39"/>
<clue>This failure to degrade IkappaBalpha may underlie both the observed decrease in NFkappaB induction and the IL-2 receptor expression in TNF-<clueType>treated</clueType> T cells during aging.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E26">
<type class="Protein_catabolism"/>
<theme idref="T33"/>
<clue>This <cluePolarity>failure</cluePolarity> to <clueType>degrade</clueType> IkappaBalpha may underlie both the observed decrease in NFkappaB induction and the IL-2 receptor expression in TNF-treated T cells during aging.</clue>
</event>
<event KT="Other" id="E27">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<clue>This failure to degrade IkappaBalpha may underlie both the observed decrease in NFkappaB <clueType>induction</clueType> and the IL-2 receptor expression in TNF-treated T cells during aging.</clue>
</event>
<event KT="Other" id="E28">
<type class="Gene_expression"/>
<theme idref="T27"/>
<clue>This failure to degrade IkappaBalpha may underlie both the observed decrease in NFkappaB induction and the IL-2 receptor <clueType>expression</clueType> in TNF-treated T cells during aging.</clue>
</event>
<event KT="Other" id="E29">
<type class="Negative_regulation"/>
<theme idref="E27"/>
<clue>This failure to degrade IkappaBalpha may underlie both the observed <clueType>decrease</clueType> <linkTheme>in</linkTheme> NFkappaB induction and the IL-2 receptor expression in TNF-treated T cells during aging.</clue>
</event>
<event KT="Other" id="E30">
<type class="Negative_regulation"/>
<theme idref="E28"/>
<clue>This failure to degrade IkappaBalpha may underlie both the observed <clueType>decrease</clueType> <linkTheme>in</linkTheme> NFkappaB induction and the IL-2 receptor expression in TNF-treated T cells during aging.</clue>
</event>
<event CL="L1" KT="Analysis" id="E31" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E26"/>
<clue>This failure to degrade IkappaBalpha <clueKT><clueCL>may</clueCL></clueKT> <clueType>underlie</clueType> both the observed decrease in NFkappaB induction and the IL-2 receptor expression <clueLoc>in TNF-treated T cells</clueLoc> <clueTime>during aging</clueTime>.</clue>
</event>
<event CL="L1" KT="Analysis" id="E32" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E29"/>
<cause idref="E26"/>
<clue>This failure to degrade IkappaBalpha <clueKT><clueCL>may</clueCL></clueKT> <clueType>underlie</clueType> both the observed decrease in NFkappaB induction and the IL-2 receptor expression <clueLoc>in TNF-treated T cells</clueLoc> <clueTime>during aging</clueTime>.</clue>
</event>
<sentence id="S8">Thus, decreased <term id="T41" lex="proteasome" sem="Protein_complex">proteasome</term>-mediated <term id="A44" sem="Other">degradation</term> may be central to <term id="T42" lex="immune_dysfunction" sem="Other">immune dysfunction</term> that accompanies <term id="A4" sem="Other">aging</term>.</sentence>
<event KT="Other" id="E33">
<type class="Positive_regulation"/>
<theme idref="A44"/>
<cause idref="T41"/>
<clue>Thus, decreased proteasome-<clueType>mediated</clueType> degradation may be central to immune dysfunction that accompanies aging.</clue>
</event>
<event KT="Other" id="E34">
<type class="Negative_regulation"/>
<theme idref="E33"/>
<clue>Thus, <clueType>decreased</clueType> proteasome-mediated degradation may be central to immune dysfunction that accompanies aging.</clue>
</event>
<event CL="L1" KT="Analysis" id="E35">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<cause idref="E34"/>
<clue><clueKT>Thus</clueKT>, decreased proteasome-mediated degradation <clueCL>may</clueCL> be <clueType>central</clueType> <linkTheme>to</linkTheme> immune dysfunction that accompanies aging.</clue>
</event>
<event KT="Fact" id="E36">
<type class="Correlation"/>
<theme idref="T42"/>
<theme idref="A4"/>
<clue>Thus, decreased proteasome-mediated degradation may be central to immune dysfunction that <clueType>accompanies</clueType> aging.</clue>
</event>
<sentence id="S9">Copyright 1999 Academic Press.</sentence>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
